Solmi M, Radua J, Olivola M, Croce E, Soardo L, Salazar de Pablo G, et al. Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies. Mol Psychiatry. 2021;27:281–95.

Article  PubMed  PubMed Central  Google Scholar 

Correll CU, Solmi M, Croatto G, Schneider LK, Rohani-Montez SC, Fairley L, et al. Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or attenuating factors. World Psychiatry. 2022;21:248–71.

Article  PubMed  PubMed Central  Google Scholar 

Solmi M, Taipale H, Holm M, Tanskanen A, Mittendorfer-Rutz E, Correll CU, et al. Effectiveness of antipsychotic use for reducing risk of work disability: results from a within-subject analysis of a Swedish National Cohort of 21,551 patients with first-episode nonaffective psychosis. Am J Psychiatry. 2022;179:938–46.

Article  PubMed  Google Scholar 

Leucht S, Leucht C, Huhn M, Chaimani A, Mavridis D, Helfer B, et al. Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: systematic review, bayesian meta-analysis, and meta-regression of efficacy predictors. Am J Psychiatry. 2017;174:927–42.

Article  PubMed  Google Scholar 

Jääskeläinen E, Juola P, Hirvonen N, McGrath JJ, Saha S, Isohanni M, et al. A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull. 2013;39:1296–306.

Article  PubMed  Google Scholar 

Cuijpers P, Karyotaki E, Weitz E, Andersson G, Hollon SD, van Straten A. The effects of psychotherapies for major depression in adults on remission, recovery and improvement: a meta-analysis. J Affect Disord. 2014;159:118–26.

Article  PubMed  Google Scholar 

Gueorguieva R, Chekroud AM, Krystal JH. Trajectories of relapse in randomised, placebo-controlled trials of treatment discontinuation in major depressive disorder: an individual patient-level data meta-analysis. Lancet Psychiatry. 2017;4:230–7.

Article  PubMed  PubMed Central  Google Scholar 

Leichsenring F, Steinert C, Rabung S, Ioannidis JPA. The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta-analytic evaluation of recent meta-analyses. World Psychiatry. 2022;21:133–45.

Article  PubMed  PubMed Central  Google Scholar 

Fleury MJ, Djouini A, Huỳnh C, Tremblay J, Ferland F, Ménard JM, et al. Remission from substance use disorders: a systematic review and meta-analysis. Drug Alcohol Depend. 2016;168:293–306.

Article  PubMed  Google Scholar 

Meehan AJ, Lewis SJ, Fazel S, Fusar-Poli P, Steyerberg EW, Stahl D, et al. Clinical prediction models in psychiatry: a systematic review of two decades of progress and challenges. Mol Psychiatry. 2022;27:2700–8.

Article  PubMed  PubMed Central  Google Scholar 

Ledermann JA, Oza AM, Lorusso D, Aghajanian C, Oaknin A, Dean A, et al. Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial. Lancet Oncol. 2020;21:710–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fusar-Poli P, Hijazi Z, Stahl D, Steyerberg EW. The science of prognosis in psychiatry: a review. JAMA Psychiatry. 2018;75:1289–97.

Article  PubMed  Google Scholar 

Salazar de Pablo G, Studerus E, Vaquerizo-Serrano J, Irving J, Catalan A, Oliver D, et al. Implementing precision psychiatry: a systematic review of individualized prediction models for clinical practice. Schizophr Bull. 2021;47:284–97.

Article  PubMed  Google Scholar 

Gates M, Gates A, Pieper D, Fernandes RM, Tricco AC, Moher D, et al. Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement. BMJ. 2022;378:e070849.

Article  PubMed  PubMed Central  Google Scholar 

Højlund M, Haddad PM, Correll CU. Limitations in research on maintenance treatment for individuals with schizophrenia. JAMA Psychiatry. 2022;79:85–6.

Article  PubMed  Google Scholar 

Højlund M, Kemp AF, Haddad PM, Neill JC, Correll CU. Standard versus reduced dose of antipsychotics for relapse prevention in multi-episode schizophrenia: a systematic review and meta-analysis of randomised controlled trials. Lancet Psychiatry. 2021;8:471–86.

Article  PubMed  Google Scholar 

Taipale H, Tanskanen A, Luykx JJ, Solmi M, Leucht S, Correll CU, et al. Optimal doses of specific antipsychotics for relapse prevention in a nationwide cohort of patients with schizophrenia. Schizophr Bull. 2022;48:774–84.

Article  PubMed  PubMed Central  Google Scholar 

Sabé M, Pallis K, Solmi M, Crippa A, Sentissi O, Kaiser S. Comparative effects of 11 antipsychotics on weight gain and metabolic function in patients with acute schizophrenia: a dose-response meta-analysis. J Clin Psychiatry. 2023;84:45463.

Article  Google Scholar 

Correll CU, Kishimoto T, Nielsen J, Kane JM. Quantifying clinical relevance in the treatment of schizophrenia. Clin Ther. 2011;33:B16–39.

Article  PubMed  PubMed Central  Google Scholar 

Levine SZ, Rabinowitz J, Engel R, Etschel E, Leucht S. Extrapolation between measures of symptom severity and change: an examination of the PANSS and CGI. Schizophr Res. 2008;98:318–22.

Article  PubMed  Google Scholar 

Andreasen NC, Carpenter WT, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry. 2005;162:441–9.

Article  PubMed  Google Scholar 

Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:4008.

Article  Google Scholar 

Wolff R, Moons K, Riley R, Whiting P, Westwood M, Collins G, et al. PROBAST: a tool to assess the risk of bias and applicability of prediction model studies. Ann Intern Med. 2019;170:51–8.

Article  PubMed  Google Scholar 

Hyer MM, Phillips LL, Neigh GN. Sex differences in synaptic plasticity: hormones and beyond. Front Mol Neurosci. 2018;11:266.

Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16:626–38.

Article  CAS  PubMed  Google Scholar 

Villa A, Vegeto E, Poletti A, Maggi A. Estrogens, neuroinflammation, and neurodegeneration. Endocr Rev. 2016;37:372–402.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mangold CA, Wronowski B, Du M, Masser DR, Hadad N, Bixler GV, et al. Sexually divergent induction of microglial-associated neuroinflammation with hippocampal aging. J Neuroinflamm. 2017;14:141.

Article  Google Scholar 

Solmi M, Suresh Sharma M, Osimo EF, Fornaro M, Bortolato B, Croatto G, et al. Peripheral levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and interleukin-1β across the mood spectrum in bipolar disorder: a meta-analysis of mean differences and variability. Brain Behav Immun. 2021;97:193–203.

Article  CAS  PubMed  Google Scholar 

Pillinger T, Osimo EF, Brugger S, Mondelli V, McCutcheon RA, Howes OD. A meta-analysis of immune parameters, variability, and assessment of modal distribution in psychosis and test of the immune subgroup hypothesis. Schizophr Bull. 2019;45:1120–33.

Article  PubMed  Google Scholar 

Davis EJ, Broestl L, Abdulai-Saiku S, Worden K, Bonham LW, Miñones-Moyano E, et al. A second X chromosome contributes to resilience in a mouse model of Alzheimer’s disease. Sci Transl Med. 2020;12:eaaz5677.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Christov-Moore L, Simpson EA, Coudé G, Grigaityte K, Iacoboni M, Ferrari PF. Empathy: gender effects in brain and behavior. Neurosci Biobehav Rev. 2014;46:604–27.

Article  PubMed  PubMed Central  Google Scholar 

Correll CU, Galling B, Pawar A, Krivko A, Bonetto C, Ruggeri M, et al. Comparison of early intervention services vs treatment as usual for early-phase psychosis: a systematic review, meta-analysis, and meta-regression. JAMA Psychiatry Am Med Assoc. 2018;75:555–65.

Article  Google Scholar 

Solmi M, Croatto G, Piva G, Rosson S, Fusar-Poli P, Rubio JM, et al. Efficacy and acceptability of psychosocial interventions in schizophrenia: systematic overview and quality appraisal of the meta-analytic evidence. Mol Psychiatry. 2023;28:354–68.

Article  PubMed  Google Scholar 

Salazar de Pablo G, Solmi M, Vaquerizo-Serrano J, Radua J, Passina A, Morsillo P, et al. Primary prevention of depression: an umbrella review of controlled interventions. J Affect Disord. 2021;294:957–70.

Article  PubMed  Google Scholar 

Salazar De Pablo G, De Micheli A, Solmi M, Oliver D, Catalan A, Verdino V, et al. Universal and selective interventions to prevent poor mental health outcomes in young people: systematic review and meta-analysis. Harv Rev Psychiatry. 2021;29:196–215.

Article  PubMed  Google Scholar 

Fusar-Poli P, Correll C, Arango C, Berk M, Patel V, Ioannidis J. Preventive psychiatry: a blueprint for improving the mental health of young people. World Psychiatry. 2021;20:200–21.

Article  PubMed  PubMed Central  Google Scholar 

Wolitzky-Taylor K, Dour H, Zinbarg R, Mineka S, Vrshek-Schallhorn S, Epstein A, et al. Experiencing core symptoms of anxiety and unipolar mood disorders in late adolescence predicts disorder onset in early adulthood. Depress Anxiety. 2014;31:207–13.

Article  PubMed  Google Scholar 

Köhler CA, Evangelou E, Stubbs B, Solmi M, Veronese N, Belbasis L, et al. Mapping risk factors for depression across the lifespan: an umbrella review of evidence from meta-analyses and Mendelian randomization studies. J Psychiatr Res. 2018;103:189–207.

Article  PubMed  Google Scholar